735 related articles for article (PubMed ID: 25894149)
1. T-regulatory cells in chronic rejection versus stable grafts.
Al-Wedaie F; Farid E; Tabbara K; El-Agroudy AE; Al-Ghareeb SM
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():170-6. PubMed ID: 25894149
[TBL] [Abstract][Full Text] [Related]
2. Human leukocyte antigen G and renal allograft transplant.
Farid E; Al-Wedaie F; Tabbara K; El-Agroudy AE; Al-Ghareeb SM
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():371-6. PubMed ID: 25894193
[TBL] [Abstract][Full Text] [Related]
3. The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation.
Korczak-Kowalska G; Wierzbicki P; Bocian K; Klosowska D; Niemczyk M; Wyzgal J; Korecka A; Durlik M; Chmura A; Paczek L; Górski A
Transplant Proc; 2007 Nov; 39(9):2721-3. PubMed ID: 18021968
[TBL] [Abstract][Full Text] [Related]
4. Increased interleukin-10 production without expansion of CD4+CD25+ T-regulatory cells in early stable renal transplant patients on calcineurin inhibitors.
Mittal SK; Sharma RK; Gupta A; Naik S
Transplantation; 2009 Aug; 88(3):435-41. PubMed ID: 19667950
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of CD4
McRae JL; Chia JS; Pommey SA; Dwyer KM
Nephrology (Carlton); 2017 Jul; 22(7):505-512. PubMed ID: 27517975
[TBL] [Abstract][Full Text] [Related]
7. An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantigens in clinically stable renal transplant recipients.
Akl A; Jones ND; Rogers N; Bakr MA; Mostafa A; El Shehawy el M; Ghoneim MA; Wood KJ
Transpl Int; 2008 Jan; 21(1):65-73. PubMed ID: 17887959
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy.
Krystufkova E; Sekerkova A; Striz I; Brabcova I; Girmanova E; Viklicky O
Nephrol Dial Transplant; 2012 Jun; 27(6):2576-82. PubMed ID: 22167587
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus versus cyclosporine therapy increases circulating regulatory T cells, but does not protect renal transplant patients given alemtuzumab induction from chronic allograft injury.
Ruggenenti P; Perico N; Gotti E; Cravedi P; D'Agati V; Gagliardini E; Abbate M; Gaspari F; Cattaneo D; Noris M; Casiraghi F; Todeschini M; Cugini D; Conti S; Remuzzi G
Transplantation; 2007 Oct; 84(8):956-64. PubMed ID: 17989600
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus did not affect CD4(+)CD25(high) forkhead box p3(+)T cells of peripheral blood in renal transplant recipients.
Chu ZQ; Ji Q
Transplant Proc; 2013; 45(1):153-6. PubMed ID: 23375290
[TBL] [Abstract][Full Text] [Related]
11. Foxp3+ T cells in peripheral blood of renal transplant recipients and clinical correlations.
Lin WX; Christiansen D; Fu LL; Roberts MA; Sandrin MS; Ierino FL
Nephrology (Carlton); 2012 May; 17(4):415-22. PubMed ID: 22308996
[TBL] [Abstract][Full Text] [Related]
12. Differential monocyte STAT6 activation and CD4(+)CD25(+)Foxp3(+) T cells in kidney operational tolerance transplanted individuals.
Moraes-Vieira PM; Silva HM; Takenaka MC; Monteiro SM; Lemos F; Saitovitch D; Kalil J; Coelho V
Hum Immunol; 2010 May; 71(5):442-50. PubMed ID: 20122976
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathological analyses of chronic vascular rejection after kidney transplantation.
Shimizu T; Toma H; Shibahara R; Tsunoyama K; Izuka J; Nozaki T; Ishida H; Tanabe K; Honda K; Koike J
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():20-5. PubMed ID: 26031581
[TBL] [Abstract][Full Text] [Related]
14. Different immunosuppressive combinations on T-cell regulation in renal transplant recipients.
Fourtounas C; Dousdampanis P; Sakellaraki P; Rodi M; Georgakopoulos T; Vlachojannis JG; Mouzaki A
Am J Nephrol; 2010; 32(1):1-9. PubMed ID: 20484893
[TBL] [Abstract][Full Text] [Related]
15. Regulatory T cells and T cell depletion: role of immunosuppressive drugs.
Noris M; Casiraghi F; Todeschini M; Cravedi P; Cugini D; Monteferrante G; Aiello S; Cassis L; Gotti E; Gaspari F; Cattaneo D; Perico N; Remuzzi G
J Am Soc Nephrol; 2007 Mar; 18(3):1007-18. PubMed ID: 17287424
[TBL] [Abstract][Full Text] [Related]
16. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
17. Designation of T-cell-mediated rejection type Ib and IIa reflects the type of rejection rather than the severity in the Banff classification.
Wu K; Budde K; Schmidt D; Neumayer HH; Rudolph B
Exp Clin Transplant; 2014 Oct; 12(5):415-23. PubMed ID: 25299369
[TBL] [Abstract][Full Text] [Related]
18. Peripheral CD4+ CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors.
Meloni F; Morosini M; Solari N; Bini F; Vitulo P; Arbustini E; Pellegrini C; Fietta AM
Int Immunopharmacol; 2006 Dec; 6(13-14):2002-10. PubMed ID: 17161354
[TBL] [Abstract][Full Text] [Related]
19. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor.
Sugiyama K; Tsukaguchi M; Toyama A; Satoh H; Saito K; Nakagawa Y; Takahashi K; Tanaka S; Onda K; Hirano T
Exp Clin Transplant; 2014 Jun; 12(3):195-9. PubMed ID: 24907718
[TBL] [Abstract][Full Text] [Related]
20. Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade.
Chavez H; Beaudreuil S; Abbed K; Taoufic Y; Kriaa F; Charpentier B; Durrbach A
Transpl Immunol; 2007 Jun; 17(4):243-8. PubMed ID: 17493526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
